Helixgate https://validator.w3.org/feed/docs/rss2.html Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more Home STAT+: CMS recalculates Medicare Advantage star ratings again, adding more volatility to program STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy Moderna flu vaccine wins unanimous support from FDA panel New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises Impact of Early Life Adversity on Epigenome at Molecular Level Mapped in Macaques Ebola cases increase almost 40% in a week as death toll passes 200 IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings cAMPfield lands $180M to build gut disease drug At FDA, ‘caretaker mode’ is better than power trip mode Moderna’s flu candidate sails through FDA advisory committee in unanimous votes New biotech cAMPfield emerges with $180M to reshape IBD treatment STAT+: Shingles vaccine may lower dementia risk, new study finds From fragile skin to living medicine: Lessons from RDEB STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more China Sets Framework for Advanced Therapeutic Development Moderna mulls deals to rescue German BioNTech plants from closure: report Nirrin Technologies and S.T. Japan Partner on Next-Gen Protein Quantitation Tech Six of the biggest health news stories today Verastem deprioritizes pancreatic cancer work after ‘decent, but not great’ data shadowed by Revolution Biogen makes up to $1B immuno play with RayThera takeover Could a new weight loss approach have longer term benefits than GLP-1s? GSK, Spero’s oral antibiotic wins first FDA nod for complicated UTI STAT+: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept Super-potent synthetic opioids called nitazenes are spreading across the U.S. Opinion: Congress should embrace strategic health diplomacy Therapy enables 89% survival rate in myeloma patients  Ones to watch: 4 biotechs with recent Series B raises (that are also hiring) RFK Jr. presents $700 million in mental health funding, but experts say grants aren’t new STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts say Personalized Cartilage Graft Developed for Life-Threatening Infant Airway Narrowing FTC, four state AGs sue transgender health group over care standards Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killing UniQure to file gene therapy for approval, reflecting major shifts at FDA Analytics Map Purification Optimization Tradeoffs Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B On the chopping block? When layoffs may and may not lurk around the corner Kardigan extends biotech’s streak of big IPOs with $400M haul Age-Related Inflammation Linked to R-Loop Nucleic Acids, Opens Therapies UniQure plans resubmission for Huntington’s gene therapy after FDA reverses course—again UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far? Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact Convert nonresponder insights into smarter drug development strategies in immunology Publisher Correction: Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein